Edition:
United Kingdom

Audentes Therapeutics Inc (BOLD.OQ)

BOLD.OQ on NASDAQ Stock Exchange Global Market

38.80USD
22 Jul 2019
Change (% chg)

$-0.00 (-0.00%)
Prev Close
$38.80
Open
$38.29
Day's High
$39.79
Day's Low
$38.29
Volume
218,213
Avg. Vol
155,646
52-wk High
$42.04
52-wk Low
$18.00

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Matthew Patterson

47 2018 Chairman of the Board, Chief Executive Officer

Natalie Holles

46 2018 President, Chief Operating Officer

Thomas Schuetz

58 2013 Co-Founder, Independent Director

Thomas Soloway

52 2019 Chief Financial Officer, Executive Vice President

Mark Meltz

45 2019 Senior Vice President, General Counsel